Navigation Links
Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007

SAN DIEGO, June 19, 2007 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. today announced that data featuring its approved diabetes drugs, BYETTA(R) (exenatide) injection and SYMLIN(R) (pramlintide acetate) injection, and its pipeline candidates will be presented at the American Diabetes Association's (ADA) 67th Annual Scientific Sessions being held in Chicago, IL from June 22 to 26. The company will also host an investor presentation during the meeting that will be available by webcast. ADA is one of the largest scientific meetings for endocrinologists and other health care professionals involved in diabetes research and delivery of diabetes care.

Data from several studies will be highlighted in oral presentations and poster sessions that will provide insight into Amylin's approved diabetes drugs, BYETTA and SYMLIN and the company's research and development programs. Additional information will also be presented during two symposia focused on the multihormonal approach to treatment of diabetes and obesity, and the role of incretin-based therapies in type 2 diabetes.

"Our activities at this year's ADA will reinforce the important therapeutic benefits of BYETTA and SYMLIN and focus on novel peptide hormones and their potential to treat obesity," said Daniel M. Bradbury, President and Chief Executive Officer of Amylin Pharmaceuticals, Inc. "We are dedicated to bringing innovative medicines with life-changing therapeutic potential to patients. Our broad clinical program is designed to continue transforming the care of diabetes and obesity."

    KEY AMYLIN ABSTRACTS BEING PRESENTED AT ADA:


    1. Oral: "Less Hypoglycemia with Exenatide Versus Insulin Glargine,

       Despite Similar HbA1c Improvement in Patients with T2DM Adjunctively

       Treated with Metformin" will be presented by Michael E. Trautmann, M.D.

       on Sunday, June 24 at 3:45 PM CT (4:45 PM ET).


    2. Oral: 
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:12/24/2014)... Mexico , Dec. 24, 2014  Novastem, ... of its first patient in its study for ... the American Stroke Association, ischemic strokes account for ... to enroll qualified patients in the study, entitled ... Administration of Allogeneic Mesenchymal Stem Cells and Intrathecal ...
(Date:12/24/2014)... PRINCETON, N.J. , Dec. 24, 2014 /PRNewswire/ ... Company), a late-stage biopharmaceutical company developing products that ... inflammation, oncology and biodefense, announced today that on ... registered public offering. The Company raised ... offering and intends to use the net proceeds ...
(Date:12/24/2014)... , December 24, 2014 ... at an average rate of 8.1%. The US has ... knee and spine surgeries are the common orthopedic procedures ... have a lower penetration. Increased number of product recalls ... Non-metallic orthopedic devices have gained popularity in the industry ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
... AURORA, Ohio , June 25 ... medical repair parts for hospital equipment, has been honored ... by Inside Business Magazine.  Now in its 13th year, ... industry,s greatest accomplishments by honoring local companies for their ...
... Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix ... the publication of an article in the June ... protection from mucosal and systemic ricin intoxication by intradermal ... ricin toxin. The article was authored by the Company,s ...
Cached Medicine Technology:PartsSource Wins 2010 Manny Award for Workplace Environment 2Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 2Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 3Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 4Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 5Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 6Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 7
(Date:12/25/2014)... 26, 2014 “Every three months the trends ... A-line sweetheart evening dress will be one of the hottest ... of Yunx.co.uk says. Today, the company releases 26 A-line sweetheart ... to 80% off. , “We are trying our best ... with our latest designs. Along with affordable prices, we provide ...
(Date:12/25/2014)... December 25, 2014 Recently, BellasDress ... on all its wedding dresses. BellasDress has chosen their ... for gift choices for the holiday season. , ... pick suitable wedding gowns here at discount prices. The ... experience at its website. , “All our ...
(Date:12/25/2014)... 25, 2014 Recently, LunaDress.co.uk has updated its blog ... related accessories. Now, all of the models at LunaDress.co.uk come with ... groom lifts the wedding veil can turn out to be a ... A wedding veil can always bring surprise to a wedding. On ... how to choose veils for a big day . , ...
(Date:12/25/2014)... 24, 2014 (HealthDay News) -- Among early stage breast ... than half of one percent will eventually develop leukemia ... reveals. The finding comes from a review of ... and 2007, and it suggests that the risk for ... experts had previously thought. "The frequency of bone ...
(Date:12/25/2014)... SmileStix ” was featured on NewsWatch as part of its ... on the iOS, Android, and Windows markets. Andrew Tropeano, a ... review and shared with viewers how this is an application ... goes, “A picture says a thousand words.” It’s true. There ... image, because each picture holds a unique and special meaning. ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... blood transfusion services for major hospitals throughout Washington ... provider of mobile productivity and management software, announced ... solution has been deployed by the Puget Sound ... access to wireless data and applications as they ...
... collection; simplifies UDS reportingTAMPA, Fla., March 24 ... integrated electronic health records and community health ... (FQHC) nationwide, Sage today announced that Family Health ... HealthLinc, formerly Hilltop Community Health Center, have selected ...
... Steps to Increase Participation in the School Breakfast ... L. Zahorchak today ate breakfast with 3rd graders ... breakfast programs and announce steps the department is ... who start the day with a healthy breakfast ...
... Veteran to Lead ItCOSTA MESA, Calif., March 24 ... it has hired Army Reserve officer Kirk Harrington, a ... as head of its newly-established warfighter division. Harrington is ... by the United States Department of State as a ...
... Cellegy Common Stock Expected to be Approximately 1: 9.929060BOYERTOWN, ... Board: CLGY) today announced that the stockholders of both ... merger of the two companies at stockholder meetings held ... subject to customary closing conditions, is expected to close ...
... March 24 Avidas(TM) Pharmaceuticals, a privately held, ... women,s health, today announced the launch of Scalacort(TM) ... in one patient convenience kit.Scalacort DK includes Scalacort ... in a clear fragrance-free base. Scalacort relieves itching ...
Cached Medicine News:Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 2Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 3Health News:NetMotion Wireless Boosts Mobile Productivity for Puget Sound Blood Center 4Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 2Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 3Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 4Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 5Health News:Community Health Centers Select Sage Intergy CHC Community Health Management System 6Health News:PA Education Secretary Emphasizes Importance of Breakfast for Student Performance 2Health News:Oxygen Biotherapeutics, Inc. Establishes Warfighter Division 2Health News:Oxygen Biotherapeutics, Inc. Establishes Warfighter Division 3Health News:Cellegy and Adamis Stockholders Approve Merger Transaction and Related Proposals 2Health News:Cellegy and Adamis Stockholders Approve Merger Transaction and Related Proposals 3Health News:Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit 2Health News:Avidas(TM) Pharmaceuticals Introduces Scalacort(TM) DK Which Offers Three Scalp Solutions in One Patient Convenience Kit 3
Toothed pituitary rongeur. Straight....
Micro cup pituitary forceps, semi-malleable shafts....
Teardrop dissector. 90, 5 mm....
Papavero-caspar specula for trans-sphenoidal hypophysectomy....
Medicine Products: